Science Explorer Interactive view Map
Company · Vöcklabruck · Austria

EVER Neuro Pharma (Austria)

Research works
49
▼ 61% vs 2013–17
Citations
1.2k
24.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: EVER Neuro Pharma (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.33× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 9.32× its world share, 0 worksImmunology and Micro…Neuroscience: 27.73× its world share, 2 worksNeuroscienceMathematics: 7.04× its world share, 0 worksMathematicsMedicine: 1.07× its world share, 1 worksMedicineNursing: 5.63× its world share, 0 worksNursingPsychology: 0.54× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Neuroscience, 27.7×. Every wedge is a field page.

Who are the top researchers at EVER Neuro Pharma (Austria)?

Ranked on the composite score, Herbert Moessler lead among researchers whose main affiliation is EVER Neuro Pharma (Austria).

  1. 1 Herbert Moessler Austria · #470,990 worldwide 53 citations · 22 works
All ranked researchers at EVER Neuro Pharma (Austria)

Which keywords describe research at EVER Neuro Pharma (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Alzheimer's Disease, Neuroprotection, Ischemic Stroke, Retinal Ganglion Cells, Mitochondrial Dysfunction, Cerebrolysin and Citicoline.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Oxidative Stress23▲ 26×12 topics
  2. Alzheimer's Disease16▲ 120×5 topics
  3. Neuroprotection15▲ 84×6 topics
  4. Ischemic Stroke13▲ 203×3 topics
  5. Retinal Ganglion Cells13▲ 203×2 topics
  6. Mitochondrial Dysfunction13▲ 73×3 topics
  7. Cerebrolysin13▲ 997×1 topic
  8. Citicoline13▲ 997×1 topic
  9. Neurodegenerative Diseases9▲ 83×2 topics
  10. Neuroprotective Effects8▲ 135×3 topics
  11. Memory Impairment6▲ 367×2 topics
  12. Cerebral Hypoperfusion6▲ 411×1 topic
  13. Vascular Cognitive Impairment6▲ 411×1 topic
  14. White Matter Lesions6▲ 334×2 topics
  15. Antioxidant4▲ 11×7 topics
  16. Inflammation4▲ 3.4×13 topics
  17. Antioxidant Activity4▲ 13×4 topics
  18. Acetylcholinesterase3▲ 219×1 topic
  19. Cholinesterase Inhibitors3▲ 219×1 topic
  20. Rhodiola Rosea3▲ 637×1 topic
  21. Salidroside3▲ 637×1 topic
  22. Diabetes2▲ 7.6×3 topics
  23. Exercise Performance2▲ 58×2 topics
  24. Lipoic Acid2▲ 263×1 topic
  25. Pyruvate Dehydrogenase Complex2▲ 263×1 topic
  26. Neuroinflammation2▲ 12×4 topics
  27. Metabolism2▲ 4.8×3 topics
  28. Aging1▲ 5.4×3 topics
  29. Cancer1▲ 2.0×8 topics
  30. Cerebral Blood Flow1▲ 33×2 topics
  31. Neurodegeneration1▲ 8.4×6 topics
  32. Carnosine1▲ 67×1 topic
  33. ß-Alanine Supplementation1▲ 67×1 topic
  34. Consolidation1▲ 53×1 topic
  35. Memory1▲ 8.9×2 topics
  36. Sleep1▲ 53×1 topic
  37. Health Effects1▲ 3.4×2 topics

Which research topics does EVER Neuro Pharma (Austria) publish most on?

By volume in 2022–2025: Neurological Disorders and Treatments, Neurological Disease Mechanisms and Treatments, Medicinal Plants and Bioactive Compounds and Statistical Methods in Clinical Trials.

  1. 1 Neurological Disorders and Treatments Neurology 1 works
  2. 2 Neurological Disease Mechanisms and Treatments Neurology 0 works
  3. 3 Medicinal Plants and Bioactive Compounds Molecular Biology 0 works
  4. 4 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  5. 5 Clinical Laboratory Practices and Quality Control Physiology 0 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
  8. 8 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
  9. 9 Trace Elements in Health Nutrition and Dietetics 0 works
  10. 10 Alzheimer's disease research and treatments Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.8%not open57.2%

World: 28% of research is openly available.

with international co-authors72.1%domestic only27.9%

World: 19% is written across borders.

How has EVER Neuro Pharma (Austria)'s research output changed?

Output in 2018–2022 was 61% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.